Chinook Therapeutics Ownership 2024 | Who Owns Chinook Therapeutics Now?


OverviewForecastChart

Institutional Ownership

81.54%

Insider Ownership

2.19%

Retail Ownership

16.26%

Institutional Holders

195.00

Chinook Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AMERICAN INTERNATIONAL GROUP, INC.----27,923-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----1,294,656-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----59,152-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----587,576-100.00%-Sep 30, 2023
BARCLAYS PLC----109,656-100.00%-Sep 30, 2023
FMR LLC----3,590-100.00%-Sep 30, 2023
DIMENSIONAL FUND ADVISORS LP----1,336,934-100.00%-Sep 30, 2023
METROPOLITAN LIFE INSURANCE CO/NY----3,169-100.00%-Sep 30, 2023
AMERICAN CENTURY COMPANIES INC----15,060-100.00%-Sep 30, 2023
TEACHER RETIREMENT SYSTEM OF TEXAS----12,491-100.00%-Sep 30, 2023
GAMCO INVESTORS, INC. ET AL----35,650-100.00%-Sep 30, 2023
NEW YORK STATE COMMON RETIREMENT FUND----47,595-100.00%-Sep 30, 2023
STRS OHIO----7,600-100.00%-Sep 30, 2023
CREDIT SUISSE AG/----51,931-100.00%-Sep 30, 2023
CITIGROUP INC----104,573-100.00%-Sep 30, 2023
FISHER ASSET MANAGEMENT, LLC----22,820-100.00%-Sep 30, 2023
STATE OF WISCONSIN INVESTMENT BOARD----49,436-100.00%-Sep 30, 2023
UBS ASSET MANAGEMENT AMERICAS INC----24,360-100.00%-Sep 30, 2023
HSBC HOLDINGS PLC----442,815-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----375,239-100.00%-Sep 30, 2023

Chinook Therapeutics's largest institutional shareholder is AMERICAN INTERNATIONAL GROUP, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AMERICAN INTERNATIONAL GROUP, INC.----27,923-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----1,294,656-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----59,152-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----587,576-100.00%-Sep 30, 2023
BARCLAYS PLC----109,656-100.00%-Sep 30, 2023
FMR LLC----3,590-100.00%-Sep 30, 2023
DIMENSIONAL FUND ADVISORS LP----1,336,934-100.00%-Sep 30, 2023
METROPOLITAN LIFE INSURANCE CO/NY----3,169-100.00%-Sep 30, 2023
AMERICAN CENTURY COMPANIES INC----15,060-100.00%-Sep 30, 2023
TEACHER RETIREMENT SYSTEM OF TEXAS----12,491-100.00%-Sep 30, 2023
GAMCO INVESTORS, INC. ET AL----35,650-100.00%-Sep 30, 2023
NEW YORK STATE COMMON RETIREMENT FUND----47,595-100.00%-Sep 30, 2023
STRS OHIO----7,600-100.00%-Sep 30, 2023
CREDIT SUISSE AG/----51,931-100.00%-Sep 30, 2023
CITIGROUP INC----104,573-100.00%-Sep 30, 2023
FISHER ASSET MANAGEMENT, LLC----22,820-100.00%-Sep 30, 2023
STATE OF WISCONSIN INVESTMENT BOARD----49,436-100.00%-Sep 30, 2023
UBS ASSET MANAGEMENT AMERICAS INC----24,360-100.00%-Sep 30, 2023
HSBC HOLDINGS PLC----442,815-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----375,239-100.00%-Sep 30, 2023

The largest Chinook Therapeutics shareholder by % of total assets is AMERICAN INTERNATIONAL GROUP, INC.. The company owns 0.00 shares of Chinook Therapeutics (KDNY), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LINDBROOK CAPITAL, LLC----12-100.00%-Sep 30, 2023
BELL INVESTMENT ADVISORS, INC----21-100.00%-Sep 30, 2023
PARALLEL ADVISORS, LLC----26-100.00%-Sep 30, 2023
BELLEVUE ASSET MANAGEMENT, LLC----27-100.00%-Sep 30, 2023
SPIRE WEALTH MANAGEMENT----30-100.00%-Sep 30, 2023
RIGGS ASSET MANAGMENT CO. INC.----65-100.00%-Sep 30, 2023
SIGNATUREFD, LLC----68-100.00%-Sep 30, 2023
WASHINGTON TRUST ADVISORS, INC.----72-100.00%-Sep 30, 2023
DAIWA SECURITIES GROUP INC.----230-100.00%-Sep 30, 2023
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.----876-100.00%-Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.----880-100.00%-Sep 30, 2023
NATIXIS----1,352-100.00%-Sep 30, 2023
NISA INVESTMENT ADVISORS, LLC----1,674-100.00%-Sep 30, 2023
CUTLER GROUP LLC / CA----2,700-100.00%-Sep 30, 2023
RUSSELL INVESTMENTS GROUP, LTD.----3,121-100.00%-Sep 30, 2023
METROPOLITAN LIFE INSURANCE CO/NY----3,169-100.00%-Sep 30, 2023
CWM, LLC----3,190-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----3,439-100.00%-Sep 30, 2023
FMR LLC----3,590-100.00%-Sep 30, 2023
FNY INVESTMENT ADVISERS, LLC----4,000-100.00%-Sep 30, 2023

As of Sep 30 2023, Chinook Therapeutics's largest institutional buyer is LINDBROOK CAPITAL, LLC. The company purchased -12.00 stocks of KDNY, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----4,345,559-100.00%-Sep 30, 2023
BLACKROCK INC.----4,263,241-100.00%-Sep 30, 2023
ALPINE ASSOCIATES MANAGEMENT INC.----2,131,000-100.00%-Sep 30, 2023
EVENTIDE ASSET MANAGEMENT, LLC----1,927,000-100.00%-Sep 30, 2023
BAKER BROS. ADVISORS LP----1,455,202-100.00%-Sep 30, 2023
DIMENSIONAL FUND ADVISORS LP----1,336,934-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----1,294,656-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----1,232,546-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----1,060,417-100.00%-Sep 30, 2023
VIVO CAPITAL, LLC----934,879-100.00%-Sep 30, 2023
NICHOLAS INVESTMENT PARTNERS, LP----928,637-100.00%-Sep 30, 2023
CANDRIAM S.C.A.----826,155-100.00%-Sep 30, 2023
ALLIANCEBERNSTEIN L.P.----808,046-100.00%-Sep 30, 2023
NUVEEN ASSET MANAGEMENT, LLC----675,828-100.00%-Sep 30, 2023
WOODLINE PARTNERS LP----617,907-100.00%-Sep 30, 2023
BALYASNY ASSET MANAGEMENT L.P.----605,294-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----587,576-100.00%-Sep 30, 2023
HUDSON BAY CAPITAL MANAGEMENT LP----574,274-100.00%-Sep 30, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----559,062-100.00%-Sep 30, 2023
SATURN V CAPITAL MANAGEMENT LLC----524,811-100.00%-Sep 30, 2023

As of Sep 30 2023, Chinook Therapeutics's biggest institutional seller is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company sold -4.35M shares of KDNY, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----4,345,559-100.00%-Sep 30, 2023
BLACKROCK INC.----4,263,241-100.00%-Sep 30, 2023
ALPINE ASSOCIATES MANAGEMENT INC.----2,131,000-100.00%-Sep 30, 2023
EVENTIDE ASSET MANAGEMENT, LLC----1,927,000-100.00%-Sep 30, 2023
BAKER BROS. ADVISORS LP----1,455,202-100.00%-Sep 30, 2023
DIMENSIONAL FUND ADVISORS LP----1,336,934-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----1,294,656-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----1,232,546-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----1,060,417-100.00%-Sep 30, 2023
VIVO CAPITAL, LLC----934,879-100.00%-Sep 30, 2023
NICHOLAS INVESTMENT PARTNERS, LP----928,637-100.00%-Sep 30, 2023
CANDRIAM S.C.A.----826,155-100.00%-Sep 30, 2023
ALLIANCEBERNSTEIN L.P.----808,046-100.00%-Sep 30, 2023
NUVEEN ASSET MANAGEMENT, LLC----675,828-100.00%-Sep 30, 2023
WOODLINE PARTNERS LP----617,907-100.00%-Sep 30, 2023
BALYASNY ASSET MANAGEMENT L.P.----605,294-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----587,576-100.00%-Sep 30, 2023
HUDSON BAY CAPITAL MANAGEMENT LP----574,274-100.00%-Sep 30, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----559,062-100.00%-Sep 30, 2023
SATURN V CAPITAL MANAGEMENT LLC----524,811-100.00%-Sep 30, 2023
GOLDMAN SACHS GROUP INC----508,062-100.00%-Sep 30, 2023
PENTWATER CAPITAL MANAGEMENT LP----465,000-100.00%-Sep 30, 2023
BAILLIE GIFFORD & CO----463,945-100.00%-Sep 30, 2023
HSBC HOLDINGS PLC----442,815-100.00%-Sep 30, 2023
MORGAN STANLEY----408,746-100.00%-Sep 30, 2023
SEGANTII CAPITAL MANAGEMENT LTD----400,000-100.00%-Sep 30, 2023
ROCK SPRINGS CAPITAL MANAGEMENT LP----396,280-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----375,239-100.00%-Sep 30, 2023
ENSIGN PEAK ADVISORS, INC----359,480-100.00%-Sep 30, 2023
VERSOR INVESTMENTS LP----348,543-100.00%-Sep 30, 2023
SAND GROVE CAPITAL MANAGEMENT LLP----315,973-100.00%-Sep 30, 2023
ALTIUM CAPITAL MANAGEMENT LP----305,000-100.00%-Sep 30, 2023
IKARIAN CAPITAL, LLC----283,464-100.00%-Sep 30, 2023
D. E. SHAW & CO., INC.----282,154-100.00%-Sep 30, 2023
KRYGER CAPITAL LTD----244,657-100.00%-Sep 30, 2023
DEUTSCHE BANK AG\----238,918-100.00%-Sep 30, 2023
BANK OF NEW YORK MELLON CORP----217,625-100.00%-Sep 30, 2023
RAFFERTY ASSET MANAGEMENT, LLC----208,207-100.00%-Sep 30, 2023
TWO SIGMA ADVISERS, LP----186,880-100.00%-Sep 30, 2023
HRT FINANCIAL LP----174,189-100.00%-Sep 30, 2023
LMR PARTNERS LLP----164,578-100.00%-Sep 30, 2023
GABELLI FUNDS LLC----154,861-100.00%-Sep 30, 2023
MAN GROUP PLC----135,000-100.00%-Sep 30, 2023
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----133,000-100.00%-Sep 30, 2023
GABELLI & CO INVESTMENT ADVISERS, INC.----128,600-100.00%-Sep 30, 2023
PICTON MAHONEY ASSET MANAGEMENT----125,000-100.00%-Sep 30, 2023
JANE STREET GROUP, LLC----116,221-100.00%-Sep 30, 2023
NAN FUNG GROUP HOLDINGS LTD----113,950-100.00%-Sep 30, 2023
AQR ARBITRAGE LLC----113,518-100.00%-Sep 30, 2023
HIGHBRIDGE CAPITAL MANAGEMENT LLC----110,000-100.00%-Sep 30, 2023
BARCLAYS PLC----109,656-100.00%-Sep 30, 2023
DRIEHAUS CAPITAL MANAGEMENT LLC----107,053-100.00%-Sep 30, 2023
CITIGROUP INC----104,573-100.00%-Sep 30, 2023
POINT72 ASSET MANAGEMENT, L.P.----102,399-100.00%-Sep 30, 2023
SWISS NATIONAL BANK----100,300-100.00%-Sep 30, 2023
RHUMBLINE ADVISERS----89,242-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----88,706-100.00%-Sep 30, 2023
UBS GROUP AG----82,016-100.00%-Sep 30, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC----77,692-100.00%-Sep 30, 2023
HIGHVISTA STRATEGIES LLC----76,021-100.00%-Sep 30, 2023
ALGERT GLOBAL LLC----73,406-100.00%-Sep 30, 2023
EHP FUNDS INC.----70,000-100.00%-Sep 30, 2023
CENTIVA CAPITAL, LP----61,734-100.00%-Sep 30, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO----60,000-100.00%-Sep 30, 2023
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----59,856-100.00%-Sep 30, 2023
SG AMERICAS SECURITIES, LLC----59,342-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----59,152-100.00%-Sep 30, 2023
CARMIGNAC GESTION----56,842-100.00%-Sep 30, 2023
CREDIT SUISSE AG/----51,931-100.00%-Sep 30, 2023
WATER ISLAND CAPITAL LLC----51,468-100.00%-Sep 30, 2023
STATE OF WISCONSIN INVESTMENT BOARD----49,436-100.00%-Sep 30, 2023
ALPS ADVISORS INC----49,166-100.00%-Sep 30, 2023
NEW YORK STATE COMMON RETIREMENT FUND----47,595-100.00%-Sep 30, 2023
FORA CAPITAL, LLC----41,648-100.00%-Sep 30, 2023
HENNION & WALSH ASSET MANAGEMENT, INC.----40,219-100.00%-Sep 30, 2023
WOLVERINE ASSET MANAGEMENT LLC----39,326-100.00%-Sep 30, 2023
INVESCO LTD.----39,106-100.00%-Sep 30, 2023
OLYMPIAD RESEARCH LP----38,931-100.00%-Sep 30, 2023
PROFUND ADVISORS LLC----38,127-100.00%-Sep 30, 2023
GAMCO INVESTORS, INC. ET AL----35,650-100.00%-Sep 30, 2023
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----34,677-100.00%-Sep 30, 2023
CSS LLC/IL----32,291-100.00%-Sep 30, 2023
METLIFE INVESTMENT MANAGEMENT, LLC----30,585-100.00%-Sep 30, 2023
EQUITEC PROPRIETARY MARKETS, LLC----28,300-100.00%-Sep 30, 2023
BCK CAPITAL MANAGEMENT LP----28,107-100.00%-Sep 30, 2023
AMERICAN INTERNATIONAL GROUP, INC.----27,923-100.00%-Sep 30, 2023
SIMPLEX TRADING, LLC----25,538-100.00%-Sep 30, 2023
VIRTU FINANCIAL LLC----25,428-100.00%-Sep 30, 2023
SIMPLIFY ASSET MANAGEMENT INC.----25,000-100.00%-Sep 30, 2023
PRINCIPAL FINANCIAL GROUP INC----24,599-100.00%-Sep 30, 2023
UBS ASSET MANAGEMENT AMERICAS INC----24,360-100.00%-Sep 30, 2023
MANUFACTURERS LIFE INSURANCE COMPANY, THE----23,422-100.00%-Sep 30, 2023
VOYA INVESTMENT MANAGEMENT LLC----22,939-100.00%-Sep 30, 2023
FISHER ASSET MANAGEMENT, LLC----22,820-100.00%-Sep 30, 2023
JOURNEY STRATEGIC WEALTH LLC----22,257-100.00%-Sep 30, 2023
MARQUETTE ASSET MANAGEMENT, LLC----22,000-100.00%-Sep 30, 2023
PROSHARE ADVISORS LLC----20,973-100.00%-Sep 30, 2023
MOORE CAPITAL MANAGEMENT, LP----20,000-100.00%-Sep 30, 2023
LEGATO CAPITAL MANAGEMENT LLC----19,963-100.00%-Sep 30, 2023
VOLORIDGE INVESTMENT MANAGEMENT, LLC----18,119-100.00%-Sep 30, 2023

Chinook Therapeutics's largest sold out institutional shareholder by shares sold is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., sold -4.35M shares, valued at -, as of undefined.

Chinook Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
IndexIQ ETF Trust0.19%442,247--Jan 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.13%59,063--Mar 31, 2024
TEKLA HEALTHCARE INVESTORS0.11%91,800--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.08%42,644--Mar 31, 2024
NEXPOINT FUNDS I0.07%276,176--Dec 31, 2023
Gabelli 787 Fund, Inc.0.07%6,000--Jan 31, 2024
Comstock Funds, Inc.0.07%1,500--Jan 31, 2024
FRANKLIN STRATEGIC SERIES0.06%534,679--Jan 31, 2024
VICTORY VARIABLE INSURANCE FUNDS0.06%31,020--Mar 31, 2024
LORD ABBETT SECURITIES TRUST0.06%265,876--Jan 31, 2024
MERGER FUND0.06%454,343--Mar 28, 2024
MERGER FUND VL0.04%5,437--Mar 28, 2024
Federated Hermes Equity Funds0.03%646,233--Jan 31, 2024
PUTNAM INVESTMENT FUNDS0.03%125,900--Jan 31, 2024
Humankind Benefit Corp0.02%541--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%11,642--Mar 31, 2024
Virtus Event Opportunities Trust0.02%47,939--Mar 28, 2024
FIDELITY COMMONWEALTH TRUST0.02%57,150--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.02%109,768--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%100,364--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%8,984--Mar 31, 2024
SSGA FUNDS0.01%6,290--Feb 29, 2024
VICTORY PORTFOLIOS0.01%382,200--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,391--Mar 31, 2024
GABELLI INVESTOR FUNDS INC0.01%22,000--Dec 29, 2023
FIDELITY SELECT PORTFOLIOS0.01%579,106--Feb 29, 2024
ALPS ETF Trust0.01%105,434--Feb 29, 2024
JPMORGAN INSURANCE TRUST0.01%106,800--Mar 31, 2023
VANGUARD INDEX FUNDS0.01%2,829,182--Mar 31, 2024
Nushares ETF Trust0.01%43,991--Jan 31, 2024
Federated Hermes MDT Series0.01%14,070--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%2,409,317--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,163--Mar 31, 2024
FORUM FUNDS II0.00%4,876--Jan 31, 2024
BNY Mellon Strategic Funds, Inc.0.00%10,880--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%22,900--Mar 31, 2024
RYDEX VARIABLE TRUST0.00%5,009--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.00%261,381--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%168,074--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%154,677--Feb 29, 2024
FEDERATED HERMES INSURANCE SERIES0.00%15,546--Mar 31, 2024
ALPS ETF Trust0.00%43,685--Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.00%13,315--Jan 31, 2024
DRIEHAUS MUTUAL FUNDS0.00%27,819--Mar 28, 2024
SSGA FUNDS0.00%1,258--Feb 29, 2024
SSGA FUNDS0.00%1,258--Feb 29, 2024
ETFis Series Trust I0.00%4,052--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%7,306--Mar 31, 2024
RYDEX SERIES FUNDS0.00%10,091--Dec 31, 2023
North Square Investments Trust0.00%21,700--Jan 31, 2024
ProFunds0.00%25,260--Mar 31, 2024
Calvert Variable Products, Inc.0.00%5,545--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%429,265--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%57,135--Mar 31, 2024
Calvert Variable Products, Inc.0.00%4,790--Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%30,052--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%4,274--Mar 31, 2024
Principal Exchange-Traded Funds0.00%18,242--Mar 31, 2024
PUTNAM VARIABLE TRUST0.00%54,400--Mar 31, 2024
Direxion Shares ETF Trust0.00%201,610--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%37,734--Mar 31, 2024
OLD WESTBURY FUNDS INC0.00%143,935--Jan 31, 2024
SunAmerica Specialty Series0.00%560--Apr 30, 2021
Brinker Capital Destinations Trust0.00%64,941--Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%18,446--Jan 31, 2024
JPMORGAN INSURANCE TRUST0.00%11,740-520-4.24%Mar 31, 2023
NORTHERN FUNDS0.00%118,165--Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%809,068--Jan 31, 2024
GDL FUND0.00%1,000--Dec 29, 2023
Voya VARIABLE PORTFOLIOS INC0.00%22,939--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%500--Dec 31, 2023
Global X Funds0.00%26,043--Jan 31, 2024
VANGUARD WORLD FUND0.00%144,130--Feb 29, 2024
THRIVENT SERIES FUND INC0.00%63,335--Mar 28, 2024
Dimensional ETF Trust0.00%239,127--Jan 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%17,055--Mar 31, 2024
NEUBERGER BERMAN ALTERNATIVE FUNDS0.00%6,650--Jan 31, 2024
Simplify Exchange Traded Funds0.00%25,000--Mar 31, 2024
NORTHERN LIGHTS FUND TRUST II0.00%5,316--Mar 31, 2024
MUTUAL FUND SERIES TRUST0.00%1,927,000--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,021--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%212,058--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%48,584--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%7,048--Feb 29, 2024
SA FUNDS INVESTMENT TRUST0.00%5,000--Mar 31, 2024
RBB FUND, INC.0.00%28,057--Feb 29, 2024
Dunham Funds0.00%20,200--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%3,456--Mar 31, 2024
THRIVENT MUTUAL FUNDS0.00%26,369--Mar 28, 2024
Voya INVESTORS TRUST0.00%15,174--Mar 31, 2024
EQ ADVISORS TRUST0.00%312,430--Mar 31, 2024
RUSSELL INVESTMENT CO0.00%76,957--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%15,590--Mar 31, 2024
GPS Funds I0.00%1,180--Mar 31, 2024
SunAmerica Specialty Series0.00%109--Apr 30, 2021
SunAmerica Specialty Series0.00%109--Apr 30, 2021
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%10,022--Dec 31, 2023
Federated Hermes Global Allocation Fund0.00%1,765--Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%14,896--Jan 31, 2024
Victory Portfolios II0.00%9,248--Mar 31, 2024

Chinook Therapeutics's largest mutual fund holder by % of total assets is "IndexIQ ETF Trust", owning 442.25K shares, compromising 0.19% of its total assets.

Chinook Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2319523.42%
31 Mar, 231582.60%
31 Dec, 221541.99%
30 Sep, 2215111.03%
30 Jun, 2213628.30%
31 Mar, 221063.92%
31 Dec, 2110221.43%
30 Sep, 2184-5.62%
30 Jun, 218915.58%
31 Mar, 2177-2.53%
31 Dec, 20791216.67%
30 Sep, 206500.00%
30 Jun, 201-
31 Mar, 201-
31 Dec, 191-
30 Sep, 191-
30 Jun, 191-
31 Mar, 191-

As of 30 Jun 23, 195 institutions are holding Chinook Therapeutics's shares, representing an increase of 23.42% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2358,379,049-4.61%
31 Mar, 2361,199,0165.24%
31 Dec, 2258,150,4132.31%
30 Sep, 2256,835,7847.49%
30 Jun, 2252,874,21219.69%
31 Mar, 2244,176,4532.57%
31 Dec, 2143,070,72653.40%
30 Sep, 2128,077,7397.14%
30 Jun, 2126,206,81212.18%
31 Mar, 2123,362,011-1.15%
31 Dec, 2023,632,640378.95%
30 Sep, 204,934,248418056.61%
30 Jun, 201,180-
31 Mar, 201,180-
31 Dec, 191,180-
30 Sep, 191,180-
30 Jun, 191,180-
31 Mar, 191,180-

Chinook Therapeutics (KDNY) has 58.38M shares outstanding as of 30 Jun 23, down -4.61% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2381.54%1.09%
31 Mar, 2386.56%1.23%
31 Dec, 2284.01%1.19%
30 Sep, 2283.85%1.15%
30 Jun, 2285.30%1.49%
31 Mar, 2275.72%1.09%
31 Dec, 2183.35%2.11%
30 Sep, 2162.87%1.76%
30 Jun, 2159.75%1.94%
31 Mar, 2155.44%1.61%
31 Dec, 2058.60%42.78%
30 Sep, 2011.70%149341646.43%
30 Jun, 200.00%35714.29%
31 Mar, 200.00%35714.29%
31 Dec, 190.00%35714.29%
30 Sep, 190.00%35714.29%
30 Jun, 190.00%35714.29%
31 Mar, 190.00%-

As of 30 Jun 23, Chinook Therapeutics is held by 81.54% institutional shareholders, representing a 1.09% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2312458.97%
31 Mar, 2378-
31 Dec, 2278-21.21%
30 Sep, 2299-1.00%
30 Jun, 2210092.31%
31 Mar, 2252-29.73%
31 Dec, 217457.45%
30 Sep, 2147-21.67%
30 Jun, 2160150.00%
31 Mar, 2124-65.71%
31 Dec, 20701300.00%
30 Sep, 205-
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--100.00%
31 Mar, 191-

124 institutional shareholders have increased their position in KDNY stock as of 30 Jun 23 compared to 78 in the previous quarter (a 58.97% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2342-12.50%
31 Mar, 23484.35%
31 Dec, 224658.62%
30 Sep, 222920.83%
30 Jun, 2224-25.00%
31 Mar, 223288.24%
31 Dec, 2117-19.05%
30 Sep, 212150.00%
30 Jun, 2114-44.00%
31 Mar, 2125525.00%
31 Dec, 204-
30 Sep, 20--
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 19--

42 institutional shareholders have reduced their position in KDNY stock as of 30 Jun 23 compared to 48 in the previous quarter (a -12.50% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2319523.42%58,379,049-4.61%81.54%1.09%12458.97%42-12.50%
31 Mar, 231582.60%61,199,0165.24%86.56%1.23%78-484.35%
31 Dec, 221541.99%58,150,4132.31%84.01%1.19%78-21.21%4658.62%
30 Sep, 2215111.03%56,835,7847.49%83.85%1.15%99-1.00%2920.83%
30 Jun, 2213628.30%52,874,21219.69%85.30%1.49%10092.31%24-25.00%
31 Mar, 221063.92%44,176,4532.57%75.72%1.09%52-29.73%3288.24%
31 Dec, 2110221.43%43,070,72653.40%83.35%2.11%7457.45%17-19.05%
30 Sep, 2184-5.62%28,077,7397.14%62.87%1.76%47-21.67%2150.00%
30 Jun, 218915.58%26,206,81212.18%59.75%1.94%60150.00%14-44.00%
31 Mar, 2177-2.53%23,362,011-1.15%55.44%1.61%24-65.71%25525.00%
31 Dec, 20791216.67%23,632,640378.95%58.60%42.78%701300.00%4-
30 Sep, 206500.00%4,934,248418056.61%11.70%149341646.43%5---
30 Jun, 201-1,180-0.00%35714.29%----
31 Mar, 201-1,180-0.00%35714.29%----
31 Dec, 191-1,180-0.00%35714.29%----
30 Sep, 191-1,180-0.00%35714.29%----
30 Jun, 191-1,180-0.00%35714.29%--100.00%--
31 Mar, 191-1,180-0.00%-1---

Chinook Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell13,300$40.00$532.00K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell23,522$14.77$347.42K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell5,948$16.81$99.99K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell13,300$13.88$184.60K-
Aug 11, 2023Oxtoby Andrewofficer Chief Commercial OfficerD-ReturnSell160,000$21.82$3.49M-
Aug 11, 2023Oxtoby Andrewofficer Chief Commercial OfficerD-ReturnSell40,000---
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell1,275$40.00$51.00K-
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell26,600$16.74$445.28K-
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell4,401---
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell19,157$40.00$766.28K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell43,047$0.35$15.07K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell73,047$0.42$30.68K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell89,545$14.77$1.32M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell60,000$15.14$908.40K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell21,500$17.59$378.19K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell100,000$12.90$1.29M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell104,000$25.27$2.63M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell8,400---
Aug 11, 2023GRIFFIN MICHELLE RENEEdirector-D-ReturnSell3,300$40.00$132.00K-
Aug 11, 2023GRIFFIN MICHELLE RENEEdirector-D-ReturnSell23,522$14.77$347.42K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell13,300$40.00$532.00K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell23,522$14.77$347.42K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell5,948$16.81$99.99K-
Aug 11, 2023Thomas Dolcadirector-D-ReturnSell13,300$13.88$184.60K-
Aug 11, 2023Oxtoby Andrewofficer Chief Commercial OfficerD-ReturnSell160,000$21.82$3.49M-
Aug 11, 2023Oxtoby Andrewofficer Chief Commercial OfficerD-ReturnSell40,000---
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell1,275$40.00$51.00K-
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell26,600$16.74$445.28K-
Aug 11, 2023Krishnan Maheshdirector-D-ReturnSell4,401---
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell19,157$40.00$766.28K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell43,047$0.35$15.07K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell73,047$0.42$30.68K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell89,545$14.77$1.32M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell60,000$15.14$908.40K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell21,500$17.59$378.19K-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell100,000$12.90$1.29M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell104,000$25.27$2.63M-
Aug 11, 2023King Andrew Jamesofficer Chief Scientific OfficerD-ReturnSell8,400---
Aug 11, 2023GRIFFIN MICHELLE RENEEdirector-D-ReturnSell3,300$40.00$132.00K-
Aug 11, 2023GRIFFIN MICHELLE RENEEdirector-D-ReturnSell23,522$14.77$347.42K-

The last insider sell of Chinook Therapeutics's stock was made by Thomas Dolca on Aug 11 2023, selling 13,300 shares at $40.00 per share (valued at $532.00K).

Chinook Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20231671.49%
Q2 2023121485.71%
Q1 2023202386.96%
Q4 2022111861.11%
Q3 202298112.50%
Q2 2022103333.33%
Q1 2022141877.78%
Q4 2021101855.56%
Q3 20215862.50%
Q2 2021113366.67%
Q1 202110--
Q4 20203721850.00%
Q3 2020-6-
Q2 202011--
Q1 202075140.00%
Q4 2019-4-
Q3 201961060.00%
Q2 20191511136.36%
Q1 201961154.55%
Q4 2018-6-

1 total buy trades, and 67 total sell trades (buy/sell ratio of 0.01%) were made by Chinook Therapeutics's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-1-
Q2 2023-6-
Q1 2023-13-
Q4 2022-6-
Q3 20221250.00%
Q2 202221200.00%
Q1 2022-12-
Q4 20211520.00%
Q3 20214757.14%
Q2 202111100.00%
Q1 2021---
Q4 20207--
Q3 2020-6-
Q2 2020---
Q1 2020-2-
Q4 2019-4-
Q3 2019-7-
Q2 2019-5-
Q1 2019-2-
Q4 2018-6-

As of Q3 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Chinook Therapeutics's stocks.

Chinook Therapeutics Peer Ownership


TickerCompany
DICEDICE Therapeutics, Inc.
PLRXPliant Therapeutics, Inc.
NUVLNuvalent, Inc.
RVMDRevolution Medicines, Inc. Warrant
KALVKalVista Pharmaceuticals, Inc.
VRDNViridian Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
VTYXVentyx Biosciences, Inc.
CERECerevel Therapeutics Holdings, Inc.
RNAAvidity Biosciences, Inc.
TVTXTravere Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
ASNDAscendis Pharma A/S
ACLXArcellx, Inc.
GPCRStructure Therapeutics Inc.
PCVXVaxcyte, Inc.
SWTXSpringWorks Therapeutics, Inc.
KURAKura Oncology, Inc.

KDNY Ownership FAQ


Chinook Therapeutics is owned by institutional shareholders (81.54%), insiders (2.19%), and public (16.26%). The largest institutional shareholder of Chinook Therapeutics is AMERICAN INTERNATIONAL GROUP, INC. (0% of total shares) and the top mutual fund owner is IndexIQ ETF Trust (0.19% of total shares).

Chinook Therapeutics's major institutional shareholders are AMERICAN INTERNATIONAL GROUP, INC., FRANKLIN RESOURCES INC, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and BARCLAYS PLC. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2023, there are 195 institutional shareholders of Chinook Therapeutics.

AMERICAN INTERNATIONAL GROUP, INC owns 0 shares of Chinook Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

As of Sep 2023, FRANKLIN RESOURCES INC holds 0 shares of Chinook Therapeutics (KDNY), compromising 0% of the company, valued at $0.

WELLS FARGO & COMPANY/MN is the third largest holder of Chinook Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).